From Scarcity to Sufficiency: Understanding and Resolving the Cancer Drug Shortage in the United States
The US has been struggling with a severe cancer drug shortage for several…
Navigating the Immunoglobulin Therapy Landscape: An Overview
The Immunoglobulin Replacement Therapy (IG) market is growing, as these…
Can "Digital Vaccines" be a game-changer in lifestyle diseases?
Digital vaccines are clinically proven "no injection, no ingestion" vaccines.…
RSV vaccines: A powerful tool to protect against RSV
According tο a recent systematic analysis focusing on children younger than…
Declining confidence in childhood vaccines: A threat for today's kids.
"We cannot allow confidence in routine immunizations to become another victim…
AI in Healthcare: Navigating the Global Landscape and Strategic Insights for Pharma and Biotech Companies
Artificial Intelligence (AI) has emerged as a transformative force in the…
Multiple myeloma treatment: Why we still need novel scientific research.
Multiple myeloma (MM) is an incurable form of hematological cancer affecting…
Coupling state-of-the-art technologies: CRISPR in the service of CAR-T immunotherapy
Cancer is the second leading cause of death worldwide. Many research and…
Are AAVs really under threat?
Gene therapies can be the answer to treating, preventing, or curing various…
Gene delivery systems explained. "Viral vs. Non-Viral Vectors Debate"
Gene therapy is a medical approach that treats a disease by correcting the…
Do you want to gain insights into the CVC portfolios of 19 Biopharma Companies and Google? Then read below!
Over the past few years, corporate venture capital (CVC) companies backed by or…
How can we address challenges in rare disease drug development?
It is estimated that rare diseases affect more than 400 million people…
